Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) EV to EBIT (2010 - 2026)

Geron's (GERN) quarterly EV to EBIT came in at 41.73 in Q2 2026, down 1.59% year-over-year from 42.41 in Q2 2025, and down 101.03% quarter-over-quarter from 4056.87 in Q1 2026.

Analysis

Geron (GERN) EV to EBIT (2010 - 2026) Analysis & Trends

Geron has disclosed EV to EBIT across 17 years of filings, most recently posting 41.73 for Q2 2026.

  • In Q2 2026, EV to EBIT fell 1.59% year-over-year to 41.73; the TTM figure through Jun 2026 stood at 10.07 (down 52.46% YoY), while the FY2025 annual figure was 7.1, up 29.15% from the prior year.
  • EV to EBIT came in at 41.73 for Q2 2026 at Geron, down from 4056.87 in the prior quarter.
  • In the past five years, EV to EBIT ranged from a high of 4056.87 in Q1 2026 to a low of 86.79 in Q4 2024.
  • Average EV to EBIT over 5 years is 195.28, with a median of 22.12 recorded in 2025.
  • Year-over-year, EV to EBIT sank 477.34% in 2024 and jumped 11104.13% in 2026.
  • Over 5 years, EV to EBIT stood at 18.4 in 2022, then grew by 18.28% to 15.03 in 2023, then slumped by 477.34% to 86.79 in 2024, then jumped by 78.04% to 19.06 in 2025, then sank by 119.01% to 41.73 in 2026.
  • Per Business Quant data, the three most recent EV to EBIT figures were 41.73 in Q2 2026, 4056.87 in Q1 2026, and 19.06 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Geron 914.60 Mn 613.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -41.73
Mar 31, 2026 4,056.87
Dec 31, 2025 -19.06
Sep 30, 2025 -35.57
Jun 30, 2025 -41.08
Mar 31, 2025 -36.87
Dec 31, 2024 -86.79
Sep 30, 2024 -85.23
Jun 30, 2024 -31.63
Mar 31, 2024 -26.98
Dec 31, 2023 -15.03
Sep 30, 2023 -17.60
Jun 30, 2023 -25.19
Mar 31, 2023 -18.04
Dec 31, 2022 -18.40
Sep 30, 2022 -17.46
Jun 30, 2022 -13.09
Mar 31, 2022 -12.09
Dec 31, 2021 -6.82
Sep 30, 2021 -10.32